Research: Dr. Laura T. Pizzi
Interpreting and applying the tools of economic evaluation to improve health care
"I pursued applied health economics because I wanted to help shape decisions regarding the costs and real-world effectiveness of medicines and other treatments. Healthcare resources are limited, so this research is critical to informing which treatments should be covered by plans and chosen by patients and healthcare providers."
Associate Professor in
the Department of Pharmacy Practice
Research focus: Cost and cost effectiveness of pharmacological and non-pharmacological treatments with an outcomes-oriented approach to improving the efficiency of care.
- Cost effectiveness of non-pharmacological support programs for depression and dementia
- Measuring the costs of anticoagulation treatment approaches
- Cost effectiveness of screening and vaginal progesterone treatment for prevention of preterm birth
- Predictors of adherence to follow-up retinopathy care among diabetic patients of the Wills Eye Institute
Application: Her research helps determine the best use of pharmaceutical resources in the care of patients. It also helps inform industry and healthcare system policy with respect to organizational decision making and the use of pharmaceutical technologies and resources.
Premise: On average, it takes about 13 years and $932 million to bring a new drug to market. In today’s economy, that expenditure of time and money is underpinning some hard questions:
- What kinds of treatments are worth that investment?
- How can we ensure a high quality of patient care at a reasonable cost?
- How can the healthcare industry and government work together to deliver balanced policy that equally serves purchasers of healthcare services, insurers, healthcare providers and patients?
Bringing 15 years of research experience, Dr. Pizzi is the first faculty member at the Jefferson School of Pharmacy to focus on interpreting and applying the tools of economic evaluation to the challenges of today’s healthcare landscape.
Funding: Dr. Pizzi receives funding from the National Institutes of Health in collaboration with Johns Hopkins University; the Center for Disease Control in collaboration with Wills Eye Institute; and multiple pharmaceutical sponsors.
- Editorial board of the PharmacoEconomics journal and the Jefferson Health Policy Newsletter
- Faculty Council of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Co-editor of Economic Evaluation in U.S. Healthcare: Principles and Applications, 2006
- Faculty advisor for the Jefferson Student Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Media advisor for the American Pharmacists Association
- Leader of the special interest group on Vision Cost Research, Wills Vision Research Center at Jefferson